2019 annual financial data
Supernus Pharmaceuticals 2019 Net margin
Direct answer
Net margin was 28.79%.
Operating income was 148,571,000 USD and net income was 113,056,000 USD.
Operating cash flow was 143,129,000 USD.
Get free Supernus Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 392,755,000 USD
- Operating income
- 148,571,000 USD
- Net income
- 113,056,000 USD
- Operating cash flow
- 143,129,000 USD
Explore related company data
View all 2019 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Supernus Pharmaceuticals financial years